SectorBiological Technology
Established Date02/02/2018
Listing Date22/06/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees647
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressThe MediaWorks, 191 Wood Lane, London W12 7FP , United Kingdom
Business
IntroductionAutolus Therapeutics plc was incorporated in England and Wales on February 2, 2018. The company is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer and autoimmune diseases. Using the company's extensive suite of proprietary and modular T-cell programming technologies, the company is designing precisely targeted, controlled and highly active T-cell therapies designed to better identify target cells, break down their defense mechanisms, and attack and eliminate these cells.
